On December 19, 2024, Brandy Ford, Senior Vice President & Chief Accounting Officer at ScanSource Inc (SCSC, Financial), executed a sale of 1,845 shares of the company. Following this transaction, the insider now holds 9,506 shares of the company. The details of this transaction can be found in the SEC Filing.
ScanSource Inc (SCSC) is a leading provider of technology products and solutions, offering a wide range of services to its customers. The company operates in the distribution of specialty technology products, including communications, networking, and security solutions.
Over the past year, Brandy Ford has sold a total of 3,098 shares and has not made any purchases. The insider transaction history for ScanSource Inc indicates that there have been no insider buys in the past year, while there have been 17 insider sells.
On the day of the recent sale, shares of ScanSource Inc were trading at $49.38, giving the stock a market cap of $1,133.271 million. The company's price-earnings ratio stands at 15.20, which is lower than the industry median of 23.66 and also lower than the company's historical median price-earnings ratio.
With a trading price of $49.38 and a GF Value of $31.79, ScanSource Inc has a price-to-GF-Value ratio of 1.55, indicating that the stock is significantly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
